Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Bradykinin antagonists from Pfizer

Oct. 23, 1997

FDA approves RPR's Nasacort for pediatric use

Oct. 20, 1997

Switch OTCs for allergies to be introduced by Fujisawa

Oct. 17, 1997

Toxicity studies reported for new expectorant from SS Pharm.

Oct. 17, 1997

Byk Gulden describes new agents for asthma

Oct. 17, 1997

CRP-derived peptides for chronic inflammatory disorders developed at Yeda

Oct. 16, 1997

New bronchodilators from Nippon Suisan

Oct. 16, 1997

FDA actively reviewing TOBI

Oct. 13, 1997

Mutual Recognition Procedure concludes for Nasonex

Oct. 13, 1997

Vanguard Medica and Abbott collaborate on development of new oral asthma therapy

Oct. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...